YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (1558.HK)
HKD 12.54
(0.48%)
HKD 12.54
(0.48%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.63 Billion CNY | -16.73% |
| 2022 | 2.53 Billion CNY | 175.66% |
| 2021 | 918.42 Million CNY | 19.76% |
| 2020 | 766.91 Million CNY | -73.23% |
| 2019 | 2.86 Billion CNY | 180.16% |
| 2018 | 1.02 Billion CNY | 75.27% |
| 2017 | 583.4 Million CNY | 112.09% |
| 2016 | 275.07 Million CNY | 55.28% |
| 2015 | 177.14 Million CNY | 29.37% |
| 2014 | 136.93 Million CNY | 31.8% |
| 2013 | 103.89 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.08 Billion CNY | -26.19% |
| 2023 Q2 | 1.19 Billion CNY | -28.08% |
| 2023 FY | 2.1 Billion CNY | -16.73% |
| 2023 Q4 | 1.46 Billion CNY | 22.15% |
| 2022 Q4 | 1.66 Billion CNY | 93.29% |
| 2022 FY | 2.53 Billion CNY | 175.66% |
| 2022 Q2 | 863.22 Million CNY | 153.43% |
| 2021 FY | 918.42 Million CNY | 19.76% |
| 2021 Q2 | 577.8 Million CNY | 495.71% |
| 2021 Q4 | 340.61 Million CNY | -41.05% |
| 2020 Q2 | 863.9 Million CNY | -42.17% |
| 2020 FY | 766.91 Million CNY | -73.23% |
| 2020 Q4 | 96.99 Million CNY | -88.77% |
| 2019 FY | 2.86 Billion CNY | 180.16% |
| 2019 Q4 | 1.49 Billion CNY | 8.99% |
| 2019 Q2 | 1.37 Billion CNY | 162.72% |
| 2018 FY | 1.02 Billion CNY | 75.27% |
| 2018 Q4 | 521.73 Million CNY | 4.18% |
| 2018 Q2 | 500.79 Million CNY | 24.18% |
| 2017 Q2 | 180.12 Million CNY | 44.89% |
| 2017 FY | 583.4 Million CNY | 112.09% |
| 2017 Q4 | 403.28 Million CNY | 123.9% |
| 2016 Q2 | 150.75 Million CNY | 65.78% |
| 2016 FY | 275.07 Million CNY | 55.28% |
| 2016 Q4 | 124.31 Million CNY | -17.54% |
| 2015 Q2 | 86.2 Million CNY | 10.94% |
| 2015 Q4 | 90.93 Million CNY | 5.49% |
| 2015 FY | 177.14 Million CNY | 29.37% |
| 2014 Q2 | 59.22 Million CNY | 73.05% |
| 2014 Q4 | 77.7 Million CNY | 31.2% |
| 2014 FY | 136.93 Million CNY | 31.8% |
| 2013 FY | 103.89 Million CNY | 0.0% |
| 2013 Q4 | 34.22 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 24.42 Million HKD | -10674.509% |
| Grand Pharmaceutical Group Limited | 3.86 Billion HKD | 31.837% |
| Extrawell Pharmaceutical Holdings Limited | 35.52 Million HKD | -7307.228% |
| Wai Yuen Tong Medicine Holdings Limited | 353.93 Million HKD | -643.521% |
| Qianhai Health Holdings Limited | 17.1 Million HKD | -15287.475% |
| Lee's Pharmaceutical Holdings Limited | 590.99 Million HKD | -345.279% |
| Essex Bio-Technology Limited | 1.22 Billion HKD | -114.129% |
| Tongfang Kontafarma Holdings Limited | 503.46 Million HKD | -422.693% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -1114.78% |
| SSY Group Limited | 1.98 Billion HKD | -32.858% |
| JBM (Healthcare) Limited | 163.87 Million HKD | -1505.828% |
| Jacobson Pharma Corporation Limited | 287.34 Million HKD | -815.808% |
| China Resources Pharmaceutical Group Limited | 29.35 Billion HKD | 91.035% |